Daiichi Sankyo UK Limited

Chiltern Place, Chalfont Park, Gerrards Cross, Buckinghamshire, SL9 0BG, UK
Telephone: +44 (0)1753 482 771
Medical Information Direct Line: +44 (0)1753 482 771
Medical Information e-mail: medinfo@daiichi-sankyo.co.uk
Customer Care direct line: +44 (0)1753 482 771
Medical Information Fax: +44 (0)1753 893 894
Out of Hours Telephone: +44 (0)1748 828 818

Patient Information Leaflet last updated on the eMC: 12/10/2011
PIL OLMETEC Plus film-coated tablets

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 12/10/2011 and displayed until Current
Reasons for adding or updating:
  • Change due to harmonisation of PIL.
Updated on 29/10/2010 and displayed until 12/10/2011
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 05/05/2010 and displayed until 29/10/2010
Reasons for adding or updating:
  • Addition of information on alternative format leaflets
Updated on 09/12/2009 and displayed until 05/05/2010
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change of contra-indications
  • Change to side-effects
  • Change to information about pregnancy or lactation
Updated on 14/10/2009 and displayed until 09/12/2009
Reasons for adding or updating:
  • Individual presentations superseded by joint PIL
  • Change due to user-testing of patient information
Updated on 26/09/2006 and displayed until 14/10/2009
Reasons for adding or updating:
  • Company name change or merger
Updated on 27/04/2006 and displayed until 26/09/2006
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 26/04/2006 and displayed until 27/04/2006
Reasons for adding or updating:
  • New PIL for new product

Active Ingredients/Generics

 
   hydrochlorothiazide
   olmesartan medoxomil